Allan Bowditch, Ex-CEO of Global Healthcare for
Martin Hamblin, Joins Forces with The Ziment Group
NEW YORK, February 1,
2006 –
Allan Bowditch, a renowned and
sought after healthcare researcher responsible for
building Martin Hamblin's healthcare business over a
30 year period, has joined The Ziment Group in a
Strategic Advisor role.
"Having
known and competed with Allan for years I felt it was
high time to get him on our team" said Howard Ziment,
Chief Executive Officer of The Ziment Group. "He brings
a depth of knowledge of our industry that is
unparalleled. We are thrilled to bring someone with such
a sterling reputation for being one of the best global
healthcare market researchers in the history of our
industry to our halls."
Bowditch was
CEO of Martin Hamblin until May of 2004. He was in an
advisory role to that company through mid-2005.
“The Ziment
Group is a dynamic, diverse organization", said
Bowditch. "The opportunity to bring the expertise I have
built throughout my career to such a place has limitless
possibilities."
In his role
as Strategic Advisor, Bowditch will assist The Ziment
Group in many ways, including the continued building of
Ziment's European efforts; in product development for
all group companies and in the training and development
of Ziment staff including moderators, analytic and
project staff. He will also continue his work in
supporting the healthcare and pharmaceutical marketing
research industries through his work with industry
associations.
"Having
someone with the stature of Allan joining our
organization will really help build upon the terrific
momentum we have in our primary research business in
Europe," said Andrew Scott, Managing Director, Ziment
Europe. "We look forward to a terrific year in 2006."
In 2003
Bowditch was given a Special Award for his contribution
to Global Marketing Research by EphMRA (European
Pharmaceutical Market Research Association) across his
career. In 2005, he was given a lifetime achievement
award by PBIRG (Pharmaceutical Business Intelligence
Research Group, an organization of US based
pharmaceutical companies who conduct global market
research.
About The
Ziment Group:
The Ziment
Group consists of Ziment, a full service consultancy
offering custom marketing research for the healthcare
and pharmaceutical industries worldwide;
WebSurveyResearch which houses the largest dedicated
panel of physicians with which to conduct marketing
research through the internet; imap Research, a division
dedicated to conducting syndicated market tracking
research; and Consumer Health Sciences, which conducts
the National Health and Wellness Survey (nhwsurvey.com),
the pre-eminent source of information about the flow of
patients into physicians' offices.
The Ziment
Group is the global healthcare research brand for The
Kantar Group, the Information and Consultancy Division
of WPP, plc. For more information on the group and its
divisions, go to
www.zimentgroup.com.
<< back
